Filter
619
Filtered Results: 619
Text search:
C.
Murray
Featured
Recommendations
47
New Publications
100
Language
Document type
No document type
338
Studies & Reports
181
Guidelines
59
Manuals
24
Strategic & Response Plan
6
Fact sheets
4
Training Material
2
Situation Updates
2
Infographics
2
Resource Platforms
1
Countries / Regions
Global
34
Kenya
21
India
20
Latin America and the Carribbean
13
South Africa
13
Russia
11
Ethiopia
11
Senegal
10
Ukraine
9
Africa
9
Western and Central Europe
9
Eastern Europe
9
Sierra Leone
8
Syria
8
Nigeria
8
Burkina Faso
7
Nepal
5
Ghana
5
Guinea
5
Tanzania
5
Zambia
5
Liberia
5
Malawi
4
Middle East and North Africa
4
Paraguay
4
Namibia
4
Mali
4
Benin
3
Chile
3
Haiti
3
Congo, Democratic Republic of
3
Bangladesh
3
Uganda
3
Botswana
3
Somalia
3
Colombia
2
Rwanda
2
Cameroon
2
Peru
2
Zimbabwe
2
Mozambique
2
Cambodia
2
Guinea-Bissau
2
Venezuela
2
West and Central Africa
2
Eastern Europe and Central Asia
2
North America
2
East and Southern Africa
2
Côte d’Ivoire / Ivory Coast
2
Argentina
2
Brazil
2
Yemen
2
Indonesia
2
Myanmar / Burma
2
Madagascar
2
Pakistan
2
Lesotho
1
Togo
1
China
1
Canada
1
Congo-Brazzaville
1
Niger
1
Burundi
1
Philippines
1
USA
1
Asia
1
Germany
1
Luxembourg
1
Japan
1
Belgium
1
France
1
Spain
1
Southern Africa
1
Lebanon
1
Vietnam
1
Djibouti
1
Egypt
1
Sudan
1
South Sudan
1
Authors & Publishers
Publication Years
Category
Countries
148
Clinical Guidelines
51
Women & Child Health
46
Public Health
44
Key Resources
16
Capacity Building
10
Pharmacy & Technologies
3
Toolboxes
Mental Health
92
TB
61
Planetary Health
41
HIV
40
COVID-19
27
NCDs
27
Health Financing Toolbox
23
Disability
20
AMR
17
NTDs
16
Ebola
14
Caregiver
14
Global Health Education
12
Rapid Response
9
Natural Hazards
7
Social Ethics
7
Polio
6
Refugee
5
Conflict
5
Pharmacy
4
Specific Hazards
3
Cholera
1
Zika
1
J Glob Health Sci. 2020 Jun;2(1):e3. A group of enzootic and zoonotic protozoan infections, the leishmaniases constitute among the most severely neglected tropical diseases (NTDs) and are found in all continents except Oceania. Representing the most common infectious diseases, NTDs comprise an open-...
To enhance health co-benefits across urban policies which tackle air pollution and climate change, WHO, in cooperation with various international, national, and local partners, implemented the Urban Health Initiative (UHI) pilot project in Accra, Ghana. The Initiative prompted the health sector to u...
Forests, trees and green spaces, hereinafter ‘forests and trees’ for short, provide multiple goods and services that contribute to human health. These include medicines, nutritious foods and other non-wood forest products (NWFPs). Globally, at least 3.5 billion people use NWFPs, including medici...
This document is an output of a WHO cross-programme initiative aiming to improve the prevention, diagnosis and management of anaemia and thereby accelerate reduction in its prevalence. It comes at an important time, midway through the era of the Sustainable Development Goals, when progress in reduci...
The World health statistics report is the annual compilation of health and health-related indicators which has been published by the World Health Organization (WHO) since 2005. The 2023 edition reviews more than 50 health-related indicators from the Sustainable Development Goals (SDGs) and WHO’s T...
Adolescence, defined as the period between 10 and 19 years of age, is a developmental stage during which many psychosocial and mental health challenges emerge. There is a well-established link between mental health and HIV outcomes. Adolescents and young adults living with HIV typically have additio...
The 2018 global health financing report presents health spending data for all WHO Member States between 2000 and 2016 based on the SHA 2011 methodology. It shows a transformation trajectory for the global spending on health, with increasing domestic public funding and declining external financing. T...
Past quantitative research on health financing has focused mostly on the level and distribution of total expenditure, with little emphasis on the specific role of public funds, despite their known importance for universal health coverage (UHC). Health Accounts data do not disaggregate public expendi...
The increasing amounts of official development assistance (ODA) for health have been aimed primarily at fighting HIV/AIDS, malaria and tuberculosis. Neglected tropical diseases (NTD), one of the most serious public health burdens among the most deprived communities, have only recently drawn the atte...
I examine the effectiveness of donors in targeting the highest burden of malaria in the Democratic Republic of Congo when health information structure is fragmented. I exploit local variations in the burden of malaria induced by mining activities as well as financial and epidemiological data from he...
The Global Burden of Disease (GBD) 2010 Study has published disability-adjusted life year (DALY) data
at both regional and country levels from 1990 to 2010. Concurrently, the Institute for Health Metrics and Evaluation
(IHME) has published estimates of development assistance for health (DAH) at th...
he global architecture for providing development assistance for health (DAH)
has become increasing complex in the last decade, with many new funding agencies entering the health sector.
This study presents a detailed picture of European Union (EU) and EU member state originating DAH
between 2006 ...
Health facilities in the Region of the Americas frequently suffer the effects of health emergencies and disasters, which jeopardize their ability to provide services to the population. The STAR-H methodology helps staff responsible for health emergency and disaster risk management to identify and as...
: Development assistance for health (DAH) is one of the most important means for Japan to promote
diplomacy with developing countries and contribute to the international community. This study, for the first time,
estimated the gross disbursement of Japan’s DAH from 2012 to 2016 and clarified its...
Donor financing to low- and middle-income countries for reproductive, maternal, newborn, and child health increased substantially from 2008 to 2013. However, increased spending by donors might not improve outcomes, if funds are delivered in ways that undermine countries’ public financial managemen...
Cardiovascular disease (CVD) is the leading cause of global deaths, with the majority occurring in low- and middle-income countries (LMIC). The primary and secondary prevention of CVD is suboptimal throughout the world, but the evidence-practice gaps are much more pronounced in LMIC. Barriers at the...
Between 2012 and 2016, development assistance for HIV/AIDS decreased by 20·0%; domestic financing is therefore critical to sustaining the response to HIV/AIDS. To understand whether domestic resources could fill the financing gaps created by declines in development assistance, we aimed to track spe...
A year ago, the second Special Session of the World Health Assembly (WHASS) unanimously agreed to start a diplomatic process for a new binding instrument aimed at ensuring the international community is better prepared for the next health emergencies. The establishment of an Intergovernmental Negoti...
In 2012, all Member States of the World Health Organization (WHO) endorsed a historical target to reduce premature mortality from noncommunicable diseases
(NCD). This commitment was echoed in 2015 by the United Nations Sustainable Development Goals, which included a target to reduce premature morta...
Atherosclerotic lower-extremity peripheral artery disease (PAD) is increasingly recognized as an important cause of cardiovascular morbidity and mortality that affects more than 230 million people worldwide. Traditional cardiovascular risk factors, including advanced age, smoking, and diabetes, are ...
